6505 -- SIR Y-90 Resin Microspheres Brand Name or Equal
ID: 36C26124Q1017Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF261-NETWORK CONTRACT OFFICE 21 (36C261)MATHER, CA, 95655, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs is seeking a contractor to provide Yttrium-90 (Y-90) SIR-Spheres resin microspheres for cancer treatment at the VA Palo Alto Healthcare System. This procurement involves a sole source award to Sirtex Medical Inc., with the contract set to span from October 1, 2024, to September 30, 2025, requiring compliance with various regulatory standards for handling radioactive materials. The SIR-Spheres are critical for treating patients with unresectable cancers, ensuring safe and compliant delivery of these specialized medical supplies. Interested vendors may submit a capabilities statement to Derek L. Brown at derek.brown7@va.gov, with all responses considered at the discretion of the government.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines a solicitation and contract for providing Yttrium-90 (Y-90) SIR-Spheres, a radiopharmaceutical used in treating certain cancers, specifically to the VA Palo Alto Health Care System. The contract is set for the performance period from October 1, 2024, to September 30, 2025, with orders required to be placed at least seven days in advance. The contractor must comply with various regulatory requirements regarding the handling and labeling of radioactive materials and must be licensed by the Nuclear Regulatory Commission. Additionally, the contractor is responsible for all quality control procedures and must provide options for third-party delivery logistics. The pricing schedule includes specific items like the SIR-Spheres doses and associated delivery components with the contractor required to submit invoices electronically. Importantly, the contract stipulates adherence to numerous federal regulations and terms applicable to commercial contracts. The overarching purpose is to ensure safe and compliant delivery of specialized medical materials to support the VA’s medical services while maintaining regulatory adherence and operational efficiency.
    The Statement of Work (SOW) outlines the requirements for a project involving the provision of Yttrium-90 (Y-90) SIR-Spheres resin microspheres for cancer treatment at the VA Palo Alto Health Care System (VAPAHCS). The contractor is responsible for delivering these radiopharmaceuticals during business hours, ensuring all regulatory compliance. Key tasks include obtaining necessary licenses, maintaining adequate supply, proper labeling of products, and adhering to extensive quality control procedures in accordance with federal and state regulations. The contractor must also accept returns under specified conditions and is required to inform VAPAHCS promptly of any delivery issues. The contract spans FY 2025 and includes specific delivery protocols and observance of federal holidays. Changes to the SOW must be approved in writing by the Contracting Officer. This document serves to facilitate the procurement of medical supplies for treating patients with unresectable cancers, emphasizing compliance and operational standards.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--Notice of Intent to Award a Sole Source Procurement - Lu177 Therapy
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 17, intends to award a sole source procurement to Advanced Accelerator Applications USA Inc. for the supply of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan). This procurement includes an order for 20 units of LUTATHERA® and 100 units of PLUVICTO™, based on Novartis's confirmation that Advanced Accelerator Applications is the sole manufacturer and authorized supplier for these critical medical supplies. The timely acquisition of these items is essential for patient care within the Veterans Health Administration. Interested parties may submit capability statements within seven days of this notice; otherwise, the order will proceed without further notice. For inquiries, contact Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    6505--Radiopharmaceuticals VA San Diego Base Year Only
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide radiopharmaceuticals for the VA San Diego Healthcare System, as outlined in a Sources Sought Notice. This procurement aims to gather information on potential sources capable of meeting the requirements specified under NAICS code 325412, with a focus on ensuring compliance with federal regulations and safety standards. The contract is anticipated to be a firm-fixed-price indefinite quantity arrangement, valued at approximately $350,000 for the base year, with responses due by November 4, 2024. Interested parties should submit their capabilities statements and relevant information to Contracting Officer Adrienne Brown at adrienne.brown4@va.gov.
    6505--36C26024Q0755 PLUVICTO LU 177 / RADIOPHARMACEUTICALS Clarification that vendors submitting quotes must have current Federal Supply Schedule Contract to be considered responsible. Procurement method FAR Part 8.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Lutetium Lu 177 PLUVICTO radiopharmaceuticals for the Portland VA Medical Center. Vendors must possess a current Federal Supply Schedule (FSS) contract to ensure their quotes are considered responsible, as outlined in the solicitation amendment. This procurement is crucial for treating metastatic castration-resistant prostate cancer, emphasizing the government's commitment to meeting the medical needs of veterans. Interested parties should submit their quotes by November 8, 2024, at 1:00 PM Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    F108--Radioactive Waste Removal Services - Amendment to add Q&A
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified small businesses to provide Radioactive Waste Removal Services, specifically for the VA Boston Healthcare System. This procurement aims to manage the disposal of Low-Level Radioactive Waste (LLRW) generated from medical procedures, including waste from radionuclides such as Lu-177 and Y-90, in compliance with federal regulations. The contract is significant for maintaining health and safety standards while supporting small business participation in government contracting. Interested vendors must submit their quotes by November 8, 2024, with the contract performance period commencing on November 11, 2024. For inquiries, potential bidders should contact Contracting Officer Tara Dossiema at Tara.Dossiema@va.gov.
    6515--Radiopharmaceuticals-Tc-99m Wilmington VA Medical Center
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a market survey to identify potential vendors capable of supplying Radiopharmaceuticals Tc-99m to the Wilmington VA Medical Center in Delaware. Vendors must demonstrate their ability to deliver these critical medical supplies within two hours and comply with stringent licensing and regulatory standards, including state and federal guidelines for radioactive materials. This procurement is vital for ensuring timely healthcare services for veterans, with the contract structured as an Indefinite Delivery Indefinite Quantity (IDIQ) agreement spanning one base year and four option years. Interested parties must submit their capability statements and relevant experience by November 7, 2024, to Christa Stine, Contract Specialist, at christa.stine@va.gov.
    Brand Name Neoprobe 2400 Console, et. al.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a Neoprobe 2400 Console and associated equipment for the VA Pittsburgh Healthcare Center. This acquisition aims to replace outdated surgical equipment, enhancing the precision of cancer surgeries through the use of the Neoprobe Gamma Detection System, which is critical for accurate tissue localization during procedures. The procurement is set aside for small businesses under the NAICS code 339112, and interested vendors must submit their quotes by 4:00 PM on November 7, 2024, to the primary contact, Joanne Skaff, at joanne.skaff@va.gov. It is essential for potential offerors to monitor the solicitation website for updates and ensure compliance with all submission requirements to avoid disqualification.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    Notice of Intent to Sole Source - Extend Services for N6264520P0002 - Maintenance for Varian Linear Accelerator System
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to negotiate a sole source modification for a maintenance contract with Varian Medical Systems, Inc. for the upkeep of Government-owned Varian Linear Accelerator Radiotherapy Systems. This contract is essential for ensuring compliance with OEM specifications and maintaining high operational standards for medical equipment used in Radiology, including adherence to U.S. Navy and Joint Commission standards. The contract, structured as a firm, fixed-price agreement, will cover services from November 1, 2024, to April 30, 2025, with an option for an additional period, and interested parties must submit capability statements by November 12, 2024, to demonstrate their qualifications. For further inquiries, contact Christine Russman at christine.l.russman.civ@health.mil or Jacqueline M. Mendoza at jacqueline.m.mendoza.civ@health.mil.
    H958--Medical Health Physicist Services in support of the St Cloud VA Health Care System
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified small businesses to provide Medical Health Physicist Services in support of the St. Cloud VA Health Care System. The procurement aims to ensure compliance with safety regulations and standards related to radiation use in medical settings, emphasizing the need for certified and experienced personnel capable of performing annual evaluations and serving as radiation safety officers. This contract, valued at approximately $19 million, will cover a base year from January 1, 2025, to December 31, 2025, with four optional one-year extensions available at the government's discretion. Interested contractors must submit their quotes via email by 08:00 AM CST on November 14, 2024, and direct any technical questions to Contract Specialist Jeremy Mortice at jeremy.mortice@va.gov by November 6, 2024.